Bank of America Allocates Thirteen Percent of Health Budget to Weight Loss Drugs

According to reporting from CNBC Finance, Bank of America now spends over $250 million annually on GLP-1 medications for its staff. CEO Brian Moynihan characterized the expense as a vital investment in his 211,000 employees despite the fact that these costs have climbed from zero

According to reporting from CNBC Finance, Bank of America now spends over $250 million annually on GLP-1 medications for its staff. CEO Brian Moynihan characterized the expense as a vital investment in his 211,000 employees despite the fact that these costs have climbed from zero